Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Cohen

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Cytokine|July 16, 2014
MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cellsCrystal J DiCosmo-Ponticello, Daniel Hoover, Frederick D Coffman, et al.
Transplantation|July 20, 2002
Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patientsHelen Fernandes, Baburao Koneru, Neil Fernandes, et al.
Arthritis and Rheumatism|May 18, 2004
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateMark C Genovese, Stanley Cohen, Larry Moreland, et al.
Rheumatology and Therapy|February 23, 2018
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid ArthritisStanley Cohen, Jeffrey R Curtis, Ryan DeMasi, et al.
Advances in Therapy|November 10, 2021
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab BiosimilarWalter Reinisch, Stanley Cohen, Monica Ramchandani, et al.
ACG Case Reports Journal|May 19, 2021
Infliximab-Induced Acute Liver Failure in a Patient With Crohn's Disease Requiring Orthotopic Liver TransplantationMuhammed Mustafa Alikhan, Emad Mansoor, Sagarika Satyavada, et al.
Immunotherapy|May 11, 2022
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilarPatrick Cobb, Dietger Niederwieser, Stanley Cohen, et al.
Arthritis Research & Therapy|March 30, 2019
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritisStanley Cohen, Jose L Pablos, Karel Pavelka, et al.
Plos One|May 15, 2013
Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cellsDaniel J Hoover, Viola Zhu, Ru Chen, et al.
Inflammatory Bowel Diseases|January 7, 2010
Phase I trial of sargramostim in pediatric Crohn's diseaseJudith R Kelsen, Joel Rosh, Mel Heyman, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Cytokine|July 16, 2014
MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cellsCrystal J DiCosmo-Ponticello, Daniel Hoover, Frederick D Coffman, et al.
Transplantation|July 20, 2002
Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patientsHelen Fernandes, Baburao Koneru, Neil Fernandes, et al.
Arthritis and Rheumatism|May 18, 2004
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateMark C Genovese, Stanley Cohen, Larry Moreland, et al.
Rheumatology and Therapy|February 23, 2018
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid ArthritisStanley Cohen, Jeffrey R Curtis, Ryan DeMasi, et al.
Advances in Therapy|November 10, 2021
A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab BiosimilarWalter Reinisch, Stanley Cohen, Monica Ramchandani, et al.
ACG Case Reports Journal|May 19, 2021
Infliximab-Induced Acute Liver Failure in a Patient With Crohn's Disease Requiring Orthotopic Liver TransplantationMuhammed Mustafa Alikhan, Emad Mansoor, Sagarika Satyavada, et al.
Immunotherapy|May 11, 2022
A review of the totality of evidence in the development of ABP 798, a rituximab biosimilarPatrick Cobb, Dietger Niederwieser, Stanley Cohen, et al.
Arthritis Research & Therapy|March 30, 2019
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritisStanley Cohen, Jose L Pablos, Karel Pavelka, et al.
Plos One|May 15, 2013
Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cellsDaniel J Hoover, Viola Zhu, Ru Chen, et al.
Inflammatory Bowel Diseases|January 7, 2010
Phase I trial of sargramostim in pediatric Crohn's diseaseJudith R Kelsen, Joel Rosh, Mel Heyman, et al.
Pageof 12